President Joe Biden is touting his administration's efforts to lower medical costs
U.S. health officials are recommending that babies get a recently approved drug to protect them against a respiratory virus
The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now.
U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year
Stocks that traded heavily or had substantial price changes Monday: Tesla, Rivian rise; Apple, AstraZeneca fall
Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117
Tempus, a leader in artificial intelligence and precision medicine, today announced a prospective study ( NCT05257551 ), in collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN), that aims to identify biomarkers...
Astrazeneca: Q3 Earnings Snapshot
AstraZeneca's EVUSHELD (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorization (EUA) in the US for the pre-exposure prophylaxis...
MARSEILLE, France, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced that AstraZeneca (LSE/STO/Nasdaq: AZN)...
